The rate of clinical response was significantly greater among patients receiving 10 mg ( 37 % ) , 40 mg ( 58 % ) , or 160 mg ( 72 % ) of mongersen than among those receiving placebo ( 17 % ) ( P = 0.04 , P < 0.001 , and P < 0.001 , respectively ) .